Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

CARLSMED, INC. (CARL) Guidance & Earnings Results

On 2026-08-05 CARLSMED, INC. raised guidance: "Raised to $74-78M from…" — from its own filing, as read by EquiReason.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

CARLCARLSMED, INC.Follow CARL — free
Medical Instruments & Supplies · Healthcare
—
Price chart with a free account
Market cap
396.7M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
5 Nov, in 12 days

What management guided

each earnings 8-K · figures checked against the filing text
ReleaseDirectionWhat they said
5 Aug 26RaisedRaised to $74-78M from $72-77M · full year
5 May 26RaisedFY26 revenue raised to $72-77M from $70-75M; midpoint $74.5M representing 48% growth over 2025 · full year
25 Feb 26RaisedFY2026 revenue $70-75M, representing 44% growth at midpoint over FY2025 revenue of $50.5M · full year
6 Nov 25RaisedFY25 revenue raised to $49.0-50.0M from $45.5-47.5M · full year
28 Aug 25RaisedFY2025 revenue $45.5-47.5M, representing 67-75% growth over FY2024 · full year

CARLSMED, INC. — questions

What guidance did CARLSMED, INC. give?
On 2026-08-05: "Raised to $74-78M from $72-77M"
When does CARLSMED, INC. report earnings?
CARLSMED, INC.'s next earnings report is expected on 2026-11-05.

Every figure on this page comes from CARLSMED, INC.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.